Celsense Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Celsense Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014033
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Celsense Inc (Celsense) is a biotechnology company that develops magnetic resonance imaging detection products. The company’s products include v-sense, cell sense and voxel tracker. Its v-sense product is used to detect a range of lesions and diseases where inflammation is a hallmark such as cancer, cardiovascular disease, autoimmune disease, infectious pathogens, and injury. Celsense provides developing cell labeling protocols, validation studies, imaging experimental design, and study management services. The company’s products are used for inflammation and transplanted cells for therapeutic and diagnostic applications. It has collaboration with pharmaceutical and biotechnology organizations. Celsense is headquartered in Pittsburgh, Pennsylvania, the US.

Celsense Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Celsense Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Celsense Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Celsense Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Celsense Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Celsense Inc, Medical Devices Deals, 2011 to YTD 2017 9
Celsense Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Celsense Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Celsense Raises USD0.1 Million in Venture Financing 11
Celsense Raises Additional USD0.4 Million in Venture Financing 12
Celsense Raises USD0.24 Million in Venture Financing 13
Celsense Raises USD0.3 Million in Venture Financing 14
Celsense Raises US$0.13 Million In Venture Financing 15
Celsense Inc – Key Competitors 16
Celsense Inc – Key Employees 17
Celsense Inc – Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Corporate Communications 19
Apr 21, 2016: Celsense Board of Directors Elects Jeffrey S. Friedman M.D., Ph.D., to Board 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Celsense Inc, Pharmaceuticals & Healthcare, Key Facts 2
Celsense Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Celsense Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Celsense Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Celsense Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Celsense Inc, Medical Devices Deals, 2011 to YTD 2017 9
Celsense Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Celsense Raises USD0.1 Million in Venture Financing 11
Celsense Raises Additional USD0.4 Million in Venture Financing 12
Celsense Raises USD0.24 Million in Venture Financing 13
Celsense Raises USD0.3 Million in Venture Financing 14
Celsense Raises US$0.13 Million In Venture Financing 15
Celsense Inc, Key Competitors 16
Celsense Inc, Key Employees 17

★海外企業調査レポート[Celsense Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Development Bank of Southern Africa-エネルギー分野:企業M&A・提携分析
    Summary Development Bank of Southern Africa (DBSA) offers various leading and infrastructure development financial services. Its service offering includes debt limited non-recourse lending, mezzanine finance, and promotion of inter-regional integration and co-operation. It offers implementation serv …
  • Oltchim SA (OLT):企業の財務・戦略的SWOT分析
    Summary Oltchim SA (Oltchim) is a chemical company that manufactures and markets petrochemical products. The company offers inorganic, macro molecular and organic synthesis products. Its inorganic products include caustic soda, liquid chlorine, hydrochloric acid and sodium hypochlorite. Oltchim's ma …
  • Ck Hutchison Holdings Ltd
    Ck Hutchison Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Ck Hutchison Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • TIBCO Software, Inc.:企業のM&A・事業提携・投資動向
    TIBCO Software, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's TIBCO Software, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • San Miguel Pure Foods Company, Inc.:企業の戦略・SWOT・財務情報
    San Miguel Pure Foods Company, Inc. - Strategy, SWOT and Corporate Finance Report Summary San Miguel Pure Foods Company, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • NeuroGenetic Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary NeuroGenetic Pharmaceuticals Inc (NeuroGenetic Pharmaceuticals) is a pharmaceutical company that develops drugs for Alzheimer’s diseases. The company develops products with its gamma-secretase modulators technology. It applies multiple lead compounds for the treatment of neurodegenerative co …
  • Visa Inc:企業の戦略・SWOT・財務分析
    Visa Inc - Strategy, SWOT and Corporate Finance Report Summary Visa Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Ontario Power Generation Inc.:企業の戦略・SWOT・財務情報
    Ontario Power Generation Inc. - Strategy, SWOT and Corporate Finance Report Summary Ontario Power Generation Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • MolecularMD Corp:医療機器:M&Aディール及び事業提携情報
    Summary MolecularMD Corp (MMD) is a diagnostics solution provider that develops and commercialize molecular diagnostic tests, which are deployed and leveraged across the continuum of the drug development process. The company offers assay design and development services, sample banking and bridging s …
  • Delaware North Companies Inc:企業の戦略的SWOT分析
    Delaware North Companies Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Fabric Development Inc:企業の戦略的SWOT分析
    Fabric Development Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Soditech Ingenierie SA (SEC):企業の財務・戦略的SWOT分析
    Soditech Ingenierie SA (SEC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Crossbeta Biosciences BV:製薬・医療:M&Aディール及び事業提携情報
    Summary Crossbeta Biosciences BV (Crossbeta) is a biotech company that offers drug discovery programs for the treatment of misfolded protein diseases. The company develops drugs against Alzheimer’s, Parkinson’s, Huntington’s disease and ALS. It offers screening of oligomer-specific therapeutics and …
  • Airest S.p.A.:企業の戦略・SWOT・財務分析
    Airest S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Airest S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Steel Authority of India Ltd:戦略・SWOT・企業財務分析
    Steel Authority of India Ltd - Strategy, SWOT and Corporate Finance Report Summary Steel Authority of India Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • PT Kimia Farma (Persero) Tbk (KAEF):製薬・医療:M&Aディール及び事業提携情報
    Summary PT Kimia Farma (Persero) Tbk (Kimia Farma) manufactures, commercializes and distributes pharmaceutical products. The company provides ethical (prescription), generic and other products. It offers products in various categories including alimentary system, allergy and immune system, system an …
  • BNP Paribas Cardif:企業の戦略・SWOT・財務情報
    BNP Paribas Cardif - Strategy, SWOT and Corporate Finance Report Summary BNP Paribas Cardif - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Sri Ayudhya Capital Public Company Limited
    Sri Ayudhya Capital Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Sri Ayudhya Capital Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • The Andersons Inc (ANDE):企業の財務・戦略的SWOT分析
    The Andersons Inc (ANDE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Key Energy Services Inc (KEG):石油・ガス:M&Aディール及び事業提携情報
    Summary Key Energy Services Inc (Key) is an onshore, rig-based well servicing contractor, which offers a range of rig services. Its service line includes rig-based and coiled tubing-based well maintenance and workover services, well completion and recompletion services, fluid management services, fi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆